Shilpa Samudrala
- Long-Term Effects of COVID-19
- Platelet Disorders and Treatments
- Neurological Complications and Syndromes
- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Cerebrospinal fluid and hydrocephalus
- Heparin-Induced Thrombocytopenia and Thrombosis
- COVID-19 Clinical Research Studies
Boston University
2021
Boston Medical Center
2021
University Medical Center
2021
RCVS (Reversible Cerebral Vasoconstrictive Syndrome) is a condition associated with vasoactive agents that alter endothelial function. There growing evidence inflammation contributes to cerebrovascular disease in patients coronavirus 2019 (COVID-19). In our study, we describe the clinical features, risk factors, and outcomes of multicenter case series COVID-19.Multicenter retrospective series. We collected characteristics, imaging, COVID-19 identified at each participating site.Ten were...
To examine the breadth of cerebrovascular presentations in patients hospitalized with coronavirus disease 2019 (COVID-19) a racially and socioeconomically diverse population.